BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 29, 2025
Home » Authors » Holland Johnson

Holland Johnson

holland.johnson@clarivate.com
Articles

ARTICLES

Business pipeline illustration
Precision Medicine World Conference

Amazon’s Majmudar discusses challenges of getting novel tech to market

Jan. 24, 2020
By Holland Johnson
SANTA CLARA, Calif. – Translating novel technology into the care delivery system is not easy, according to Maulik Majmudar, medical officer at Bellevue, Wash.-based Amazon.com Inc. In fact, he said at the Precision Medicine World Conference that “it’s a hot mess.” In his presentation, Majmudar spoke about the classic barriers that prevent technologies from getting adopted at scale in a timeline that's usually feasible for early- and mid-stage startups – and even for large companies – and developing strategies to overcome those challenges.
Read More
DNA data illustration
Precision Medicine World Conference

AI, data science companies strut their stuff at PMWC

Jan. 23, 2020
By Holland Johnson
SANTA CLARA, Calif. – While many of the presentations at the Precision Medicine World Conference revolved around clinical studies and their promise for future breakthroughs in health care, a continuous stream of companies made their pitches for translating these studies into actual products that can benefit patients now.
Read More

BioWorld MedTech’s Orthopedics Extra for Jan. 22, 2020

Jan. 22, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Renovos Biologics
Read More

BioWorld MedTech’s Orthopedics Extra for Jan. 15, 2020

Jan. 15, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics.
Read More

BioWorld MedTech’s Orthopedics Extra for Jan. 8, 2020

Jan. 8, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics.
Read More

Bioworld MedTech’s Orthopedics Extra for Dec. 18, 2019

Dec. 18, 2019
By Holland Johnson
Keeping you up to date on recent developments in orthopedics.
Read More

Bioworld MedTech’s Orthopedics Extra for Dec. 11, 2019

Dec. 11, 2019
By Holland Johnson
Keeping you up to date on recent developments in orthopedics.
Read More

Bioworld MedTech’s Orthopedics Extra for Dec. 4, 2019

Dec. 4, 2019
By Holland Johnson
Keeping you up to date on recent developments in orthopedics.
Read More

Bioworld MedTech’s Orthopedics Extra

Nov. 27, 2019
By Holland Johnson
Keeping you up to date on recent developments in orthopedics.
Read More

BioWorld MedTech's Orthopedics Extra

Nov. 20, 2019
By Holland Johnson
Keeping you up to date on recent developments in orthopedics.
Read More
View All Articles by Holland Johnson

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 29, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing